Pharma Deal of the year: Johnson & Johnson to acquire Momenta for 6.5 billion USD Ruchika Sharma21 Aug 2020 3:14 PM ISTUS: Johnson & Johnson agreed to pay $6.5 billion in cash to acquire Momenta Pharmaceuticals Inc., a maker of autoimmune-disease drugs, in the...
Johnson and Johnson arm ties up with BE for COVID-19 vaccine production Ruchika Sharma15 Aug 2020 9:45 AM ISTHyderabad: Biological E Ltd has entered into an agreement with Janssen Pharmaceutica NV, part of pharma major Johnson & Johnson, for creation...
Johnson and Johnson begins human safety trial for its COVID-19 vaccine candidate Ruchika Sharma1 Aug 2020 9:15 AM ISTUS: Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys...
EU talks with Pfizer, Sanofi, JnJ on Potential COVID Vaccines Struggle To Reach Deal: Report Ruchika Sharma29 July 2020 9:30 AM ISTMilan: European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment...
Johnson and Johnson works to ramp up production of affordable COVID vaccine: top scientist Ruchika Sharma5 July 2020 9:15 AM IST"We are also scaling up capacities in other countries to further our goal to supply more than one billion doses of the vaccine globally through the...
Johnson and Johnson to stop selling talc-based baby powder in US, Canada Ruchika Sharma21 May 2020 12:10 PM ISTJ&J faces about 19,400 cases alleging its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma,...
US likely to get first access to Sanofi Covid19 Vaccine: Bloomberg Ruchika Sharma15 May 2020 6:14 PM ISTThat's because the U.S. was first in line to fund Sanofi's vaccine research, Chief Executive Officer Paul Hudson said in an interview with Bloomberg...
J&J sees recovery in coronavirus-hit medical devices unit at end of year Medical Dialogues Bureau15 April 2020 1:17 PM ISTUS: Johnson & Johnson on Tuesday said it expects its medical device business to begin recovering in the fourth quarter as elective medical...
Johnson & Johnson, ViiV Healthcare: Two injections every month or two could control HIV Pooja Bhatia Bhatia5 Nov 2015 9:07 AM ISTJohnson & Johnson and partner ViiV Healthcare, which specializes in HIV drugs, has recently shared results from the first 32 weeks of the...
